Atherosclerotic Cardiovascular Disease
📧 Sign up to get email alerts when something new happens for Atherosclerotic Cardiovascular Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-03-25Clinical Trial Update: Study in Primary Care Evaluating Inclisiran Delivery Implementation + Enhanced Support [Phase 3]
Novartis completed a Phase 3 trial evaluating how inclisiran is delivered in primary care with enhanced support, focusing on implementation …
-
CLINICAL_TRIALS trial_result · 2024-03-06Clinical Trial Update: Trial to Assess the Effect of Long Term Dosing of Inclisiran in Subjects With High CV Risk and Elevated LDL-C [Phase 3]
Phase 3 trial update evaluating long-term dosing of inclisiran in high cardiovascular risk patients with elevated LDL-C; study completed wit…
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Treatment of High and Very High riSk Dyslipidemic pAtients for the PreveNTion of CardiOvasculaR Events
A completed clinical trial update on preventing cardiovascular events in patients with high to very high risk dyslipidemia; results posted i…
-
CLINICAL_TRIALS trial_result · 2023-12-27Clinical Trial Update: Pilot Study to Evaluate the Effect of Nicotinamide Riboside on Immune Activation in Psoriasis [NA]
Pilot study assessing the effect of nicotinamide riboside on immune activation in psoriasis; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: Study on the Composite Endpoint Event of PCSK9 Inhibitor in Patients With Very High Risk of ASCVD and Cancer [Phase 4]
A phase 4 clinical trial update evaluating a PCSK9 inhibitor in patients at very high risk of ASCVD and cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-07-11Clinical Trial Update: Effect of Evolocumab on Vascular Function [Phase 4]
Phase 4 trial update investigating the effect of evolocumab on vascular function in atherosclerotic cardiovascular disease.
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: An Extension Trial of Inclisiran in Participants With Cardiovascular Disease and High Cholesterol [Phase 2]
Phase 2 extension trial update for inclisiran in participants with cardiovascular disease and high cholesterol; study completed with results…
-
CLINICAL_TRIALS trial_result · 2022-05-19Clinical Trial Update: Impact of PCSK9 Inhibitors on Coronary Microvascular Dysfunction in Patients With Atherosclerotic Cardiovascular Disease Proved by Myocardial Ischemia and Needing Coronarography [Phase 2]
Phase 2 trial exploring the impact of PCSK9 inhibitors on coronary microvascular dysfunction in patients with atherosclerotic cardiovascular…
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: Impact of Evolocumab on the Effects of Clopidogrel in Patients With High On-Treatment Platelet Reactivity [Phase 4]
Phase 4 trial evaluating how evolocumab influences the effects of clopidogrel in patients with high on-treatment platelet reactivity in athe…
-
CLINICAL_TRIALS trial_result · 2021-09-28Clinical Trial Update: Subclinical Cardiovascular Disease in Psoriatic Disease [Phase 4]
Phase 4 clinical trial update on subclinical cardiovascular disease in psoriatic disease; study completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-07-28Clinical Trial Update: Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia [Phase 3]
Phase 3 outcomes study completed; FocaSThStatin residual risk reduction with EPA in high cardiovascular risk patients with hypertriglyceride…
-
CLINICAL_TRIALS trial_result · 2021-07-01Clinical Trial Update: Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term [NA]
A completed clinical trial evaluating aspirin dosing for patients with atherosclerotic cardiovascular disease; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-06-18Clinical Trial Update: Evaluation of Exercise Treadmill Test (ETT) Indices in Participants With Cardiovascular Disease [Phase 2]
Phase 2 clinical trial evaluating Exercise Treadmill Test indices in participants with cardiovascular disease has terminated; results posted…
-
CLINICAL_TRIALS trial_result · 2021-06-02Clinical Trial Update: High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and Hypertension [Phase 4]
A Phase 4 trial comparing high-dose statin plus telmisartan versus amlodipine evaluating effects on glucose metabolism in patients with athe…
-
CLINICAL_TRIALS trial_result · 2020-12-22Clinical Trial Update: Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE) [Phase 3]
Phase 3 long-term safety and efficacy update of bempedoic acid (CLEAR Harmony OLE) completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-12-14Clinical Trial Update: Rosuvastatin/Ezetimibe Versus Rosuvastatin in ASCVD Patients With Type 2 DM [Phase 4]
A Phase 4 trial comparing rosuvastatin/ezetimibe combination vs rosuvastatin alone in patients with ASCVD and type 2 diabetes mellitus has c…
-
CLINICAL_TRIALS trial_result · 2020-12-14Clinical Trial Update: High-intensity Rosuvastatin vs. Moderate-intensity Rosuvastatin/Ezetimibe in High Atherosclerotic Cardiovascular Disease Risk Patients With Type 2 Diabetes [Phase 4]
Phase 4 clinical trial comparing high-intensity rosuvastatin versus moderate-intensity rosuvastatin/ezetimibe in patients with high ASCVD ri…
-
CLINICAL_TRIALS trial_result · 2020-10-05Clinical Trial Update: Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol [Phase 3]
Phase 3 trial update for inclisiran in participants with atherosclerotic cardiovascular disease and elevated LDL cholesterol has completed w…
-
CLINICAL_TRIALS trial_result · 2020-08-21Clinical Trial Update: Inclisiran for Subjects With ASCVD or ASCVD-Risk Equivalents and Elevated Low-density Lipoprotein Cholesterol [Phase 3]
Phase 3 trial update for inclisiran in subjects with atherosclerotic cardiovascular disease or risk-equivalents and elevated LDL cholesterol…
-
CLINICAL_TRIALS trial_result · 2020-04-27Clinical Trial Update: Evaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular Risk [Phase 3]
Phase 3 trial update assessing long-term efficacy of bempedoic acid in patients with hypercholesterolemia at high cardiovascular risk; resul…
-
CLINICAL_TRIALS trial_result · 2020-04-20Clinical Trial Update: Cardiovascular Inflammation Reduction Trial - Inflammation Imaging Study [Phase 3]
Phase 3 trial update for a study on cardiovascular inflammation imaging in vascular inflammation and atherosclerotic cardiovascular disease;…
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin Intolerant [Phase 3]
Phase 3 trial evaluating the efficacy and safety of bempedoic acid (ETC-1002) in hyperlipidemia patients intolerant to statins; study comple…
-
CLINICAL_TRIALS trial_result · 2019-12-30Clinical Trial Update: High-intensity Rosuvastatin and Moderate-intensity Rosuvastatin/Ezetimibe in ASCVD Patients [Phase 4]
A Phase 4 trial comparing high-intensity rosuvastatin to moderate-intensity rosuvastatin/ezetimibe in patients with atherosclerotic cardiova…
-
CLINICAL_TRIALS trial_result · 2019-05-17Clinical Trial Update: Trial to Evaluate the Effect of ALN-PCSSC Treatment on Low Density Lipoprotein Cholesterol (LDL-C) [Phase 2]
Phase 2 trial evaluating ALN-PCSSC treatment on LDL-C in patients with atherosclerotic cardiovascular disease and familial hypercholesterole…
-
CLINICAL_TRIALS trial_result · 2019-03-18Clinical Trial Update: ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab [Phase 3]
Phase 3 outcomes study evaluating cardiovascular outcomes after acute coronary syndrome during treatment with alirocumab (ODYSSEY Outcomes) …